Skip to content

The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive
Stock Photo: Cover May Be Different

The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline Hardcover - 2017 - 1st Edition

by Dale Bredesen

  • Used
  • Good
  • Hardcover

Description

Avery, August 2017. Hardcover. Good.
Used - Good
NZ$7.49
NZ$5.83 Shipping to USA
Standard delivery: 2 to 8 days
More Shipping Options
Ships from Next Page Bookstore, LLC (Indiana, United States)

Details

  • Title The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline
  • Author Dale Bredesen
  • Binding Hardcover
  • Edition number 1st
  • Edition 1
  • Condition Used - Good
  • Pages 320
  • Volumes 1
  • Language ENG
  • Publisher Avery
  • Date August 2017
  • Illustrated Yes
  • Features Bibliography, Illustrated, Index
  • Bookseller's Inventory # 41643
  • ISBN 9780735216204 / 0735216207
  • Weight 1.05 lbs (0.48 kg)
  • Dimensions 9.1 x 6.2 x 1.3 in (23.11 x 15.75 x 3.30 cm)
  • Themes
    • Topical: Health & Fitness
  • Library of Congress subjects Alzheimer's disease - Prevention, Alzheimer's disease - Treatment
  • Library of Congress Catalog Number 2017029515
  • Dewey Decimal Code 616.831

About Next Page Bookstore, LLC Indiana, United States

Biblio member since 2019
Seller rating: This seller has earned a 5 of 5 Stars rating from Biblio customers.

The Next Page Bookstore & More is more than just a Bookstore! Established in August 2005, we offer a variety of new & gently used books, audio books, and gift items.

Terms of Sale: 30 day return guarantee, with full refund including original shipping costs for up to 30 days after delivery if an item arrives misdescribed or damaged.

Browse books from Next Page Bookstore, LLC

Categories

About the author

Dale Bredesen, M.D., is internationally recognized as an expert in the mechanisms of neurodegenerative diseases such as Alzheimer's disease. He graduated from Caltech, then earned his M.D. from Duke University Medical Center in Durham, North Carolina. He served as chief resident in neurology at the University of California, San Francisco (UCSF) before joining Nobel laureate Stanley Prusiner's laboratory at UCSF as an NIH postdoctoral fellow. He held faculty positions at UCSF, UCLA, and the University of California, San Diego. Dr. Bredesen directed the Program on Aging at the Burnham Institute before coming to the Buck Institute in 1998 as its founding president and CEO. He is the chief medical officer of MPI Cognition.